National Asset Management, Inc. Oramed Pharmaceuticals Inc. Transaction History

National Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$12.13 - $23.82 $253,310 - $497,433	-20,883 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$8.34 - $14.59 $11,492 - $20,105	1,378 Added 7.06%	20,883 $280,000
Q1 2021 May 13, 2021	BUY	$4.22 - $11.33 $82,311 - $220,991	19,505 New	19,505 $199,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.